Mikita Sheleh @MikitaS: "🚀 $NUVB News Update..."

Poland

🚀 $NUVB (Nuvation Bio Inc) News Update - First Patient Enrolled! According to recent reports, Nuvation Bio has enrolled its first patient in its lead clinical program - a key milestone in advancing its oncology pipeline. This confirms the trial is active and progressing from theory to practice. finance.yahoo.com/news/nuvation-bio-enrolls-first-patient-113000346.html 🧠 Why This Matters • It turns the story from "potential" into "action". The trial is no longer hypothetical. • Early patient enrollment helps validate operations, regulatory alignment, and execution capabilities. • It also helps unlock downstream catalysts: midpoint data, expansion cohorts, and (eventually) registration planning. ⚠️ Risk & Considerations • Enrollment doesn’t guarantee positive results - there’s still a long way to go. • Clinical timelines often stretch; keep an eye on updates. • Market sentiment will react sharply to interim data - expectations are high. 🎯 My Take This is exactly the kind of catalyst I look for when I back biotech - first patient = a real progress signal. It reinforces my conviction in $NUVB leadership and pipeline. I remain bullish long-term, even at current levels. 🏷️ Tags for visibility: $SPX500 $QQQ (Invesco QQQ) $ETH $BTC $NVDA (NVIDIA Corporation) $TSLA (Tesla Motors, Inc.) $PLTR (Palantir Technologies Inc.) $AMPX (Amprius Technologies Inc) $GTLB (GitLab) $OPEN (Opendoor Technologies Inc)